Fig 1: Expression of anti-apoptotic proteins in HK-2 cells following treatment with ioxitalamate and/or resveratrol. (A) Representative western blots of survivin, Bcl-2, cIAP1, cIAP2 and Bcl-xL expression examined following 48 h of treatment with ioxitalamate and/or resveratrol. (B) Immunoreactivity of Bcl-2 was decreased 48 h following treatment with ioxitalamate, and resve-ratrol reversed its expression. (C) Immunoreactivity of survivin was decreased following treatment with ioxitalamate for 24 and 48 h, and resveratrol reversed its expression after 48 h of treatment. **p<0.01 and ***p<0.005.